New RSV Vaccine Reduces Hospitalizations
This is a US news story, published by Ars Technica, that relates primarily to RSV news.
US news
For more US news, you can click here:
more US newsNews about vaccine development
For more vaccine development news, you can click here:
more vaccine development newsArs Technica news
For more news from Ars Technica, you can click here:
more news from Ars TechnicaAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about
maternal vaccine. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest first RSV season news, new vaccine news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
RSV seasonArs Technica
•Health
Health
New RSV vaccine, treatment linked to dramatic fall in baby hospitalizations

85% Informative
RSV is the leading cause of hospitalization for infants in the US .
An estimated 58,00080,000 children younger than 5 years old are hospitalized each year .
Maternal antibodies generated from the vaccination pass to the fetus in the uterus and can protect a newborn in the first few months of life.
VR Score
89
Informative language
89
Neutral language
78
Article tone
formal
Language
English
Language complexity
59
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
2
Source diversity
2
Affiliate links
no affiliate links